Novel biomarkers of human growth hormone action from serum proteomic profiling using protein chip mass spectrometry

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 2, 2006, Pages 671-677

  Chung, Liping ^a   Clifford, David ^b   Buckley, Michael ^b   Baxter, Robert C ^a,c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b CSIRO   (Australia)

^c ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CUPRIC ION; HEMOGLOBIN ALPHA CHAIN; PLACEBO; RECOMBINANT GROWTH HORMONE;

ADULT; ARTICLE; ATHLETE; FEMALE; HORMONE ACTION; HORMONE RESPONSE; HUMAN; MALE; MASS SPECTROMETRY; MOLECULAR WEIGHT; MULTIVARIATE ANALYSIS; NORMAL HUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN MICROARRAY; PROTEIN PURIFICATION; PROTEOMICS; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; VALIDATION PROCESS;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; DOUBLE-BLIND METHOD; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMAN GROWTH HORMONE; HUMANS; MALE; MASS SPECTROMETRY; MULTIVARIATE ANALYSIS; PROTEIN ARRAY ANALYSIS; PROTEOMICS; ROC CURVE;

EID: 32544459721     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2005-1137     Document Type: Article

References (38)

1. Macintyre JG 1987 Growth hormone and athletes. Sports Med 4:129-142
2. Parker ML, Utiger RD, Daughaday WH 1962 Studies on human growth hormone. II. The physiological disposition and metabolic fate of human growth hormone in man. J Clin Invest 41:262-268
3. Owens D, Srivastava MC, Tompkins CV, Nabarro JD, Sonksen PH 1973 Studies on the metabolic clearance rate, apparent distribution space and plasma half-disappearance time of unlabelled human growth hormone in normal subjects and in patients with liver disease, renal disease, thyroid disease and diabetes mellitus. Eur J Clin Invest 3:284-294
4. Jorgensen JO, Pedersen SA, Thuesen L, Jorgensen J, Ingemann-Hansen T, Skakkebaek NE, Christiansen JS 1989 Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet 1:1221-1225
5. Giustina A, Veldhuis JD 1998 Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr Rev 19:717-797
6. Healy ML, Russell-Jones D 1997 Growth hormone and sport: abuse, potential benefits, and difficulties in detection. Br J Sports Med 31:267-268
7. Sonksen PH 2001 Insulin, growth hormone and sport. J Endocrinol 170:13-25
8. Dall R, Longobardi S, Ehrnborg C, Keay N, Rosen T, Jorgensen JO, Cuneo RC, Boroujerdi MA, Cittadini A, Napoli R, Christiansen JS, Bengtsson BA, Sacca L, Baxter RC, Basset EE, Sonksen PH 2000 The effect of four wk of supraphysiological growth hormone administration on the insulin-like growth factor axis in women and men. GH-2000 Study Group. J Clin Endocrinol Metab 85:4193-4200
9. Wallace JD, Cuneo RC, Baxter R, Orskov H, Keay N, Pentecost C, Dall R, Rosen T, Jorgensen JO, Cittadini A, Longobardi S, Sacca L, Christiansen JS, Bengtsson BA, Sonksen PH 1999 Responses of the growth hormone (GH) and insulin-like growth factor axis to exercise, GH administration, and GH withdrawal in trained adult males: a potential test for GH abuse in sport. J Clin Endocrinol Metab 84:3591-3601
10. Longobardi S, Keay N, Ehrnborg C, Cittadini A, Rosen T, Dall R, Boroujerdi MA, Bassett EE, Healy ML, Pentecost C, Wallace JD, Powrie J, Jorgensen JO, Sacca L 2000 Growth hormone (GH) effects on bone and collagen turnover in healthy adults and its potential as a marker of GH abuse in sports: a double blind, placebo-controlled study. The GH-2000 Study Group. J Clin Endocrinol Metab 85:1505-1512
11. Wu Z, Bidlingmaier M, Dall R, Strasburger CJ 1999 Detection of doping with human growth hormone. Lancet 353:895
12. Baxter RC, Martin JL 1986 Radioimmunoassay of growth hormone-dependent insulinlike growth factor binding protein in human plasma. J Clin Invest 78:1504-1512
13. Baxter RC 1990 Circulating levels and molecular distribution of the acid-labile (α) subunit of the high molecular weight insulin-like growth factor-binding protein complex. J Clin Endocrinol Metab 70:1347-1353
14. Ehrnborg C, Lange KH, Dall R, Christiansen JS, Lundberg PA, Baxter RC, Boroujerdi MA, Bengtsson BA, Healey ML, Pentecost C, Longobardi S, Napoli R, Rosen T 2003 The growth hormone/insulin-like growth factor-I axis hormones and bone markers in elite athletes in response to a maximum exercise test. J Clin Endocrinol Metab 88:394-401
15. Wallace JD, Cuneo RC, Bidlingmaier M, Lundberg PA, Carlsson L, Boguszewski CL, Hay J, Healy ML, Napoli R, Dall R, Rosen T, Strasburger CJ 2001 The response of molecular isoforms of growth hormone to acute exercise in trained adult males. J Clin Endocrinol Metab 86:200-206
16. Healy ML, Dall R, Gibney J, Bassett E, Ehrnborg C, Pentecost C, Rosen T, Cittadini A, Baxter RC, Sonksen PH 2005 Towards the development of a test for growth hormone abuse: a study of extreme physiological ranges of growth hormone dependent markers in 813 elite athletes in the post-competition setting. J Clin Endocrinol Metab 90:641-649
17. Yip TT, Lomas L 2002 SELDI ProteinChip array in oncoproteomic research. Technol Cancer Res Treat 1:273-280
18. Issaq HJ 2003 Application of separation technologies to proteomics research. Adv Protein Chem 65:249-269
19. Tang N, Tornatore P, Weinberger SR 2004 Current developments in SELDI affinity technology. Mass Spectrom Rev 23:34-44
20. Petricoin III EF, Ornstein DK, Paweletz CP, Ardekani A, Hackett PS, Hitt BA, Velassco A, Trucco C, Wiegand L, Wood K, Simone CB, Levine PJ, Linehan WM, Emmert-Buck MR, Steinberg SM, Kohn EC, Liotta LA 2002 Serum proteomic patterns for detection of prostate cancer. J Natl Cancer Inst 94: 1576-1578
21. Kozak KR, Amneus MW, Pusey SM, Su F, Luong MN, Luong SA, Reddy ST, Farias-Eisner R 2003 Identification of biomarkers for ovarian cancer using strong anion-exchange ProteinChips: potential use in diagnosis and prognosis. Proc Natl Acad Sci USA 100:12343-12348
22. Zhang L, Yu W, He T, Yu J, Caffrey RE, Dalmasso EA, Fu S, Pham T, Mei J, Ho JJ, Zhang W, Lopez P, Ho DD 2002 Contribution of human α-defensin 1, 2, and 3 to the anti-HIV-1 activity of CD8 antiviral factor. Science 298:995-1000
23. Tibshirani R, Hastie T, Narasimhan B, Soltys S, Shi G, Koong A, Le QT 2004 Sample classification from protein mass spectrometry, by 'peak probability contrasts.' Bioinformatics 20:3034-3044
24. Soille P 1999 Morphological image analysis: principles and applications. New York: Springer
25. Wu B, Abbott T, Fishman D, McMurray W, Mor G, Stone K, Ward D, Williams K, Zhao H 2003 Comparison of statistical methods for classification of ovarian cancer using mass spectrometry data. Bioinformatics 19:1636-1643
26. Kiiveri H 2003 A Bayesian approach to variable selection when the number of variables is very large. In: Goldstein DR, ed. Science and statistics: a festschrift for Terry Speed. Beachwood, OH: Institute of Mathematical Statistics; 127-143
27. Ebert MP, Meuer J, Wiemer JC, Schulz HU, Reymond MA, Traugott U, Malfertheiner P, Rocken C 2004 Identification of gastric cancer patients by serum protein profiling. J Proteome Res 3:1261-1266
28. Haven CJ, Howell VM, Eilers PH, Dunne R, Takahashi M, van Puijenbroek M, Furge K, Kievit J, Tan MH, Fleuren GJ, Robinson BG, Delbridge LW, Philips J, Nelson AE, Krause U, Dralle H, Hoang-Vu C, Gimm O, Morreau H, Marsh DJ, Teh BT 2004 Gene expression of parathyroid tumors: molecular subclassification and identification of the potential malignant phenotype. Cancer Res 64:7405-7411
29. Ponnampalam AP, Weston GC, Trajstman AC, Susil B, Rogers PA 2004 Molecular classification of human endometrial cycle stages by transcriptional profiling. Mol Hum Reprod 10:879-893
30. D'Ercole AJ 1996 Insulin-like growth factors and their receptors in growth. Endocrinol Metab Clin North Am 25:573-590
31. Daughaday WH 2000 Growth hormone axis overview-somatomedin hypothesis. Pediatr Nephrol 14:537-540
32. Le Roith D, Scavo L, Butler A 2001 What is the role of circulating IGF-I? Trends Endocrinol Metab 12:48-52
33. Isaksson O 2004 GH, IGF-I, and growth. J Pediatr Endocrinol Metab 17(Suppl 4):1321-1326
34. Jorgensen JO, Vahl N, Hansen TB, Skjaerbaek C, Fisker S, Orskov H, Hagen C, Christiansen JS 1998 Determinants of serum insulin-like growth factor I in growth hormone deficient adults as compared to healthy subjects. Clin Endocrinol (Oxf) 48:479-486
35. Nilsson-Ehle H, Bengtsson BA, Lindstedt G, Mellstrom D 2005 Insulin-like growth factor-1 is a predictor of blood haemoglobin concentration in 70-yr-old subjects. Eur J Haematol 74:111-116
36. Sohmiya M, Kato Y 2005 Human growth hormone and insulin-like growth factor-I inhibit erythropoietin secretion from the kidneys of adult rats. J Endocrinol 184:199-207
37. Vihervuori E, Virtanen M, Koistinen H, Koistinen R, Seppala M, Siimes MA 1996 Hemoglobin level is linked to growth hormone-dependent proteins in short children. Blood 87:2075-2081
38. Shaskey DJ, Green GA 2000 Sports haematology. Sports Med 29:27-38